These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 13162574)

  • 21. [Isopathic phenomenon in clinically normal skin in leprosy].
    RICHTER R
    Arch Klin Exp Dermatol; 1956; 202(4):307-16. PubMed ID: 13340784
    [No Abstract]   [Full Text] [Related]  

  • 22. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
    Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
    Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India.
    Rahete NP; Zodpey SP; Kamble KM
    Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of leprosy by BCG].
    PEREIRA AC
    Arq Min Leprol; 1958 Jul; 18(3):180-7; English transl 188-93. PubMed ID: 13584226
    [No Abstract]   [Full Text] [Related]  

  • 26. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering the story of Bacillus Calmette Guerin (BCG) vaccine in prevention of leprosy.
    Zodpey SP
    Indian J Public Health; 2006; 50(2):67-9. PubMed ID: 17191407
    [No Abstract]   [Full Text] [Related]  

  • 28. [BCG in the prevention of leprosy studied in the light of the conclusions of international congresses and meetings of experts of the WHO].
    CAMPOS NS
    Rev Bras Leprol; 1962; 30():55-64. PubMed ID: 14018194
    [No Abstract]   [Full Text] [Related]  

  • 29. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of leprosy with BCG].
    MONTESTRUC E; GARCIN D; BERDONNEAU R; BENOIST J
    Presse Med (1893); 1959 May; 67(27):1112-3. PubMed ID: 13667879
    [No Abstract]   [Full Text] [Related]  

  • 31. [BCG vaccination in the prevention of tuberculosis and leprosy].
    GINES AR
    Arch Urug Med Cir Espec; 1953; 43(1-2):21-6. PubMed ID: 14350976
    [No Abstract]   [Full Text] [Related]  

  • 32. [First results with BCG in prevention of leprosy].
    DE CAMPOS NS
    Actas Dermosifiliogr; 1953 Oct; 45(1):57-60. PubMed ID: 13148015
    [No Abstract]   [Full Text] [Related]  

  • 33. [Constitutional anergy; a case of lepromatous leprosy in a 9-year-old patient BCG-vaccinated at birth & at 7 years of age].
    RAMOS E; SILVA J
    Rev Bras Leprol; 1957; 25(4):401-2. PubMed ID: 13568193
    [No Abstract]   [Full Text] [Related]  

  • 34. Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG/Leishmania antigens.
    Pereira LI; Dorta ML; Pereira AJ; Bastos RP; Oliveira MA; Pinto SA; Galdino H; Mayrink W; Barcelos W; Toledo VP; Lima GM; Ribeiro-Dias F
    Am J Trop Med Hyg; 2009 Sep; 81(3):378-83. PubMed ID: 19706899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Positivation of Mitsuda reaction after BCG vaccination & its value in prevention of leprosy].
    FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1957 Apr; 18(422):1-6. PubMed ID: 13522259
    [No Abstract]   [Full Text] [Related]  

  • 36. What is the best way to use BCG to protect against leprosy: when, for whom, and how often?
    Smith WC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):48-9. PubMed ID: 15217315
    [No Abstract]   [Full Text] [Related]  

  • 37. The isopathic phenomenon of Sagher and its possible potentialities.
    WADE HW
    Int J Lepr; 1957; 25(3):263-8. PubMed ID: 13525001
    [No Abstract]   [Full Text] [Related]  

  • 38. Lichen scrofulosorum in a patient with lepromatous leprosy after BCG immunotherapy.
    Kumaran MS; Dogra S; Kaur I; Kumar B
    Lepr Rev; 2005 Jun; 76(2):170-4. PubMed ID: 16038252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reflections on leprosy in infants. Apropos of 3 personal cases].
    ROLLIER M; ROLLIER R
    Maroc Med; 1963 Jul; 42():546-55. PubMed ID: 13982531
    [No Abstract]   [Full Text] [Related]  

  • 40. Alteration of the cortisol-cortisone shuttle in leprosy type 1 reactions in leprosy patients in Hyderabad, India.
    Andersson AK; Atkinson SE; Khanolkar-Young S; Chaduvula M; Jain S; Suneetha L; Suneetha S; Lockwood DN
    Immunol Lett; 2007 Mar; 109(1):72-5. PubMed ID: 17320974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.